Revusiran (sodium)
Revusiran sodium is a 1st-generation short interfering RNA, which directed against transthyretin (TTR) mRNA. Revusiran sodium can be used for transthyretin (TTR) -mediated amyloidosis research[1].
Product Specifications
Product Name Alternative
ALN-TTRSC (sodium)
UNSPSC
12352208
Target
Small Interfering RNA (siRNA) ; Transthyretin (TTR)
Type
Oligonucleotides
Related Pathways
Epigenetics; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/revusiran-sodium.html
Purity
93.16
Solubility
10 mM in H2O
Smiles
[Revusiran(sodium)]
Molecular Weight
16121 (free acid)
References & Citations
[1]Jessica E Sutherland, et al. Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. Nucleic Acid Ther. 2020 Feb;30 (1) :33-49.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
034517-APC 200 µL
DCT, NT (DCT, TYRP2, L-dopachrome tautomerase, L-dopachrome Delta-isomerase, Tyrosinase-related protein 2) (APC) discontinued
Sign In for Pricing
View Details K6942104 1.0 µg DNA
Abcf1 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details K0727605 3x 1.0 µg
FAM66C sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details QP6496-ec-200ug 200ug
Recombinant Mouse Pituitary homeobox 3 Protein, GST, E.coli-200ug
Sign In for Pricing
View Details K3711406 1.0 µg DNA
Kcnc1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details